Document Type
Original Article
Abstract
Background: In the industrialized world, diabetic macular edoema (DME) is the leading cause of blindness in those under the age of 50. Diabetic retinopathy may begin to manifest in patients with type I (insulin-dependent) DM within 3 – 5 years after disease initiation. Nearly all diabetics will develop retinopathy by the age of twenty.
Aim of the Work: Is to evaluate the effect of subthershold micro pulse laser (SMPL) in treatment of DME with central macular thickness less than 400 m.
Patients and Methods: A Prospective, interventional comparative study was done at the Ophthalmology department and clinic of EL Zahraa and Bab EL-Shariyia University Hospitals, Cairo, Egypt.
Results: There was no clinically significant difference between both groups as regard (BCVA, CMT and AMT) pre laser and after various period of follow up. Among group I there were no statistically significant changes regarding AMT and BCVA after 6 months except CMT which shows a statistically clinically significant changes denoting high incidence of reduction of CMT. There were no statistically significant clinical changes in group II regarding AMT, CMT and BCVA after 6 months of follow up.
Conclusion: SMPL laser 532 nm is an alternative as primary treatment for DME and can substitute intravitreal injection and conventional laser photocoagulation. No visible or invisible retinal scar seen clinical or by OCT after SMPL, so it is a safe procedure and can be repeated.
Keywords
Micropulse Laser; Diabetic Macular Edema
Subject Area
Ophthalmology
How to Cite This Article
Ahmed, Aliaa Ahmed Fatouh; Hasan, Zeinab Sayed; Sayed, Sayed Abbas; and Aly, Mona El Sayed
(2023)
"The Effect of Micropulse Laser in Treatment of Diabetic Macular Edema,"
Al-Azhar International Medical Journal: Vol. 4:
Iss.
8, Article 7.
DOI: https://doi.org/10.58675/2682-339X.1930
